Analyst consensus rating
Belite Bio Analyst Rating: Strong Buy
Direct answer
Belite Bio's consensus rating is Strong Buy.
9 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $228.89.
Forecast evidence checked October 11, 2026.
Get free Belite Bio email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $154.49
- Average price target
- $228.89
- High price target
- $303.00
- Low price target
- $185.00
- Low target gap
- +19.7%
- Target upside
- +48.2%
- High target gap
- +96.1%
- Target range width
- 76.4%
- Consensus rating
- Strong Buy
- Analysts
- 9
- Evidence date
- October 11, 2026
- Valid through
- October 18, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Belite Bio?
Belite Bio has a verified Strong Buy consensus. The same dataset has an average price target of $228.89.
How far are Belite Bio's low and high targets from the recorded price?
The low target implies +19.7%, while the high target implies +96.1%.
How many analysts are included in Belite Bio's consensus?
The verified consensus includes 9 analysts.
How is Belite Bio's target upside or downside calculated?
The average target of $228.89 is divided by the recorded price of $154.49, then one is subtracted to produce +48.2%. This does not guarantee a future return.
When was Belite Bio's analyst forecast verified?
The data was verified on 2026-10-11. The dataset is valid through 2026-10-18.